Introduction 45
Inclusions consisting of the Tau protein occur in many neurological conditions with 46
Alzheimer's disease the most prominent among them. Normally, Tau is in a kinetic equilibrium 47 between a microtubule bound and free state. Under disease conditions Tau self-assembles into 48 fibrils that eventually lead to highly insoluble polymeric inclusions known as neurofibrillary 49 tangles. The underlying biophysical basis for the transition of Tau from a microtubule-associated 50 protein to an insoluble fibril is unknown. However, a clue comes from the observation that 51 polyanions, such as heparin, promote Tau fibrillization [1] . Although less effectively, RNA can 52 also induce Tau fibrillization [2, 3] , and unlike heparin, RNA is present intracellularly, making it 53 accessible to interact with Tau. 54 Our experiments began with the finding that Tau can bind RNA in living cells and 55
interestingly Tau-RNA binding shows selectivity for tRNAs. This observation along with the 56 known categorization of Tau as intrinsically disordered and its ability to spread from cell to cell 57 in a manner that resembles prions [4, 5] , suggested that Tau might share additional properties 58 with other RNA binding proteins involved in neurodegeneration. These proteins include FUS [6] , 59 , C9ORF72 [8, 9] , hnRNPA2B1 and hnRNPA1 [10, 11] all of which can undergo 60 liquid-liquid phase-separation from the surrounding aqueous medium into droplets in vitro. 61
These highly protein dense structures, known in the chemical literature as complex coacervates 62 [12, 13] , establish a liquid liquid phase state (LLPS) associated with (1) increasing protein 63 concentration, (2) tuning the salt concentration and temperature, (3) the presence of RNA 64 complexed to an intrinsically disordered protein and (4) low interfacial tension to promote fusion. 65
A consensus property of a complex coacervate is high internal fluid dynamics rooted in low 66 cohesive energy between the polyelectrolyte complexes and weakly bound water constituting the 67 fluid [13, 14] . Complex coacervate chemistry has facilitated bio-inspired coating, wet adhesion 68 and engulfment [15] [16] [17] . 69
Here we show that Tau-RNA complexes have all the properties of a complex coacervate. 70
When multiple Tau molecules weakly bind RNA and overall charge matching is achieved 71 between the polycation, Tau, and polyanion, RNA, Tau undergoes condensation and phase 72 separation into micrometer sized droplets. Remarkably, within this liquid phase-separated state 73
Tau maintains internal segment mobility and a compact conformation between two spin labels 74 around the core region of Tau known as PHF6(*) despite the molecular crowding associated with 75 coacervation. In contrast, this region undergoes irreversible fibrillization in the presence of a 76 different polyanion, heparin, which induces full extension of Tau monomers and packs 77 monomers into β-sheet assemblies. The spontaneous and reversible droplet formation suggests 78 that Tau is held in a low energy-barrier fluid state between dilute solution and complex 79 coacervate condensate with the free energy difference toggled by interactions mediated by ions. 80
However, prolonged residence in this phase state begins to induce β-sheet formation suggesting 81 that the highly condensed phase state of Tau is a precursor to fibril formation. 82 83 Results 84 Tau binds RNA in living cells 85 RNA binding to Tau in living cells was examined by PAR-iCLIP using the human Tau-86 specific antibody, HJ 8.5, in HEK 293T cells, human iPSC-derived neurons and retinoic acid-87 differentiated neuroblastoma SH-SY5Y cells. The HEK 293T cells expressed wild type full-88 length human Tau (4R2N), mutant Tau (P301L-4R2N) or mutant Tau fused to CFP (P301L, 89 4R1N) ( Fig. 1a-b, Fig. S1, Fig. S2a-c) . iPSC-derived neurons were derived from carriers of 90 4R2N Tau (Fig. 1c) , P301L Tau or a risk variant for progressive supranuclear palsy, A152T. The 91 SH-SY5Y cells expressed both Tau and the short isoform of MAP2 called MAP2c [18] (Fig. 92 S2d). Strong binding of Tau to RNA was observed in all cells, as indicated by 32 P-labeled RNA 93 bands corresponding to immunoprecipitated and cross-linked Tau-RNA complexes ( Fig. 1a -c, 94 lanes 2; Fig. S2a, lane 2) . The radioactive Tau-bound RNA band was found to run as 30-100 nt 95 (data not shown). PAR-iCLIP experiments with varying RNase concentrations did not shift the 96 32 P-labeled band, nor change its intensity (lanes 2-3 in Fig. S2b ). These experiments indicate that 97 in contrast to most known RNA-binding proteins that bind to RNA as a smear over a range of 98 sizes, Tau binds specifically and dominantly to small RNAs or RNA fragments. 99
Because small RNAs are abundant and may engage in non-specific interactions, we 100 performed multiple confirmatory controls ( Fig. S2b lanes 1, 4 and S2c lanes 3, 4), including 101 immunoprecipitation in HEK cells without Tau expression, without Tau antibody to rule out non-102 specific binding and without UV exposure to eliminate the possibility that Tau-RNA complexes 103 formed in vitro after cell lysis. Various disease mutations of Tau had no effect on the binding to 104 RNA in either the HEK cells or the human iPSC-derived neurons. Although Tau and MAP2 are 105 highly homologous in their proline rich and microtubule binding domains, MAP2 did not bind 106 RNA (Fig. S2d, lane 3) . 107
To identify the RNA types crosslinked to Tau, DNA libraries were prepared from the 108 immunoprecipitated radiolabeled bands and sequenced. In all experiments, the controls 109 consistently showed relatively few total reads and very few uniquely aligned reads ( Fig. S2e-f ). 110
We analyzed the distribution of Tau-bound RNA from the human genome by defining eight 111 regions: exons, introns, lincRNAs, snRNAs, rRNAs, miRNAs, tRNAs and intergenics. In Tau-112 expressing HEK cells, tRNAs were overwhelmingly the highest category of RNA crosslinked to 113 Tau ( Fig. 1d ). Endogenous Tau in hiPSC-derived neurons also bound tRNAs; however, 114 background RNA from introns and intergenics were relatively abundant as well ( Fig. 1e ). 115
Background RNA sequences are common in all CLIP studies, particularly for atypical RNA 116 binding proteins [19] . Despite the abundance of tRNAs in cells however, background reads from 117 CLIP experiments consistently show a paucity of tRNAs. Correcting for background reads by 118 dividing the percentage of Tau-bound RNA by the percentage of nucleotides of each category in 119 the genome demonstrated a selective enrichment of tRNAs ( Fig. 1f-g) . The specific tRNA 120 species crosslinked to Tau overlapped extensively between HEK and hiPSC-derived neuron 121 samples. Of 625 annotated tRNA loci in the human genome, 462 tRNA genes crosslinked to Tau 122 in HEK cells with 79% of them observed in all four Tau CLIP samples and 94% in at least two 123 samples. In the hiPSC-derived neurons, all 231 tRNA genes identified were also observed in the 124 HEK cells and 119 of these were verified in at least two Tau CLIP samples. The distribution of 125 the cross-linked tRNAs in HEK and hiPSC-derived neurons differed from the distribution of the 126 total tRNAs. This difference indicated that the tRNAs selected by the CLIP experiment were not 127 randomly drawn from the total tRNA pool ( Fig. S3a-b ). Among the most differentially selected 128 tRNAs by CLIP was tRNA Arg (Fig. S3c ). 129 7 136
Tau-RNA Binding Affinity and Stoichiometry 137
A gel shift assay using recombinant wild type full-length human Tau (4R2N) induced a 138 shift in unacetylated tRNA Lys (Fig. 3a) , yielding a dissociation constant (K d ) for 4R2N Tau 139 binding to tRNA of 460 ± 47 nM (Fig. 3b ). The derived Hill coefficient was 2.8, implying 140 cooperative binding of multiple Tau proteins to tRNA [20] . Isothermal titration calorimetry (ITC) 141 experiments independently confirmed the affinity of Tau binding to tRNA to yield K d = 735 ± 142 217 nM and 372 ± 9 nM for 4R2N and K18 Tau, respectively (Fig. 3c ). The dissociation constant 143 for 4R2N Tau binding to a 43 nucleotide random RNA sequence still yielded a K d = 832 ± 94 nM 144 with a Hill coefficient of 2.6 according to a gel shift assay, suggesting that Tau effectively binds 145
RNA non-specifically in vitro, although there may be differences in binding affinity. 146
Our in vitro observation further suggested that Tau binds RNA in two stages, first 147 forming a protein dimer-RNA (P 2 R) complex followed by a protein multimer-RNA (P 2n R) 148 complex, consistent with a two-stage RNA binding model reported for the protein AUF1 [21] 149 and hnRNP A1 [22] . The ITC titration experiments showed that both 4R2N and K18 Tau interact 150 with tRNA with the stoichiometry of a protein dimer ( Fig. 3c , n = 0.52 ± 0.04), while the gel 151 shift assay showed multiple bands corresponding to high molecular weight protein-RNA 152 complexes. These include a faster migrating band representing P 2 R complexes populated at 153 lower Tau:tRNA molar ratio and a slower migrating band representing P 2n R complexes 154 populated at higher Tau:tRNA molar ratios ( Fig. 3d-e ). The fraction of bound Tau (from the low 155 or high bands) was plotted as a function of Tau:tRNA molar ratios (Fig. 3f) , and compared to the 156 theoretical binding saturation curves for 1:1 to 6:1 binding stoichiometries ( Fig. 3f ). At lower 157
Tau:tRNA molar ratios, Tau and RNA form complexes at a ~2:1 ratio, while at higher Tau:tRNA 158 molar ratios, Tau and tRNA form complexes at ratios up to 6:1. We conclude that tRNA is 159 capable of binding multiple Tau proteins in a multi-step process. Judging by the absence of 160 higher stoichiometric signatures in the ITC measurement that is less sensitive to binding events 161 associated with small changes in heat, Tau:tRNA complexes that exceed a ratio of 2:1 must rely 162 on weak interactions. RNA droplets that eventually disappeared when the salt concentration was increased to 100 mM 180 or higher ( Fig. 4c-d , Fig. S5a left panel) . Droplet formation was maximal at Δtau187:tRNA 181 molar ratios of 8:1, Δtau187:poly(A) RNA molar ratios from 33:1 to 330:1 and Δtau187:poly(U) 182 RNA ratios from 267:1 to 333:1 (estimated from the molecular weight of RNAs, see Fig. S5c ). 183
Remarkably, each of these stoichiometries converge to a Δtau187:tRNA charge ratio of ~1:1, 184 irrespective of the RNA type ( Fig. 4e, Fig. S5a right panel) . Droplet formation was also 185 observed with full length Tau 4R2N and RNA, but was less robust than with Δtau187, possibly 186 due to the additional negative charges at the N-terminal segment of Tau 4R2N that would 187 diminish the electrostatic association between Tau and RNA. However, at pH 6 where the net 188 charge of Tau 4R2N is similar to Δtau187, droplets reliably formed, though yielding lower 189 number densities, and were exquisitely sensitive to salt concentration ( Fig. S5e ). Even at NaCl 190 concentrations as low as 10 mM, the droplets dissolved. In cellular environments however, 191 additional factors-charged co-constituents or posttranslational modifications of Tau-may 192 strengthen Tau-RNA associations, rendering droplet formation more favorable at higher ionic 193 strengths. Together, these observations show that droplet formation is dominated by electrostatic 194 complexation between oppositely charged polyelectrolytes, while the shielding of their excess 195 charge (by the tuning of Tau:RNA ratio) is critical to form an extended assembly constituting the 196 droplets. From this we conclude that Tau-RNA droplet formation follows a complex 197 coacervation mechanism, initiated through non-specific complexation of oppositely charged 198 polyelectrolytes and driven by the further association of these polyelectrolyte complexes to form 199 a macroscopic fluid phase by relying on weak electrostatic attractions tuned by salt concentration 200 [23] . A crucial observation is that complex coacervate droplet formation is spontaneous and fully 201 reversible through the tuning of salt concentration and Tau:RNA ratios. The convergence of 202 different Tau constructs toward the shared property of complex coacervation with different RNA 203 species present at a common charge ratio of ~1:1 leads us conclude that complex coacervate-204 driven droplet formation is an intrinsic property of Tau in the presence of RNA. 205 206 Tau in condensed droplets is in a solution state 207
Within a condensed complex coacervate, held together by non-specific and weak electrostatic 208 interactions, we expect the polyelectrolyte constituents to maintain their hydration layer and 209 remain dynamic [14, 24] . To spectroscopically track Tau exclusively from within the condensed 210 phase we first positively verified by confocal fluorescence imaging that Δtau187 was exclusively 211 localized within the droplet (Fig. 4b ). This allowed us to characterize the droplet-internal protein 212
properties. First, continuous wave electron paramagnetic resonance (cw EPR) spectral line shape 213 analysis of singly spin labeled Δtau187 at cysteine site 322, Δtau187/322C-SL, diluted with 214 diamagnetically labeled Δtau187/322C-DL (see Methods), was used to compare the protein side 215 chain dynamics and degrees of freedom of the tethered spin label of Δtau187 in dilute solution 216 state ( Fig. 4 red, f-h), in the droplet state associated with poly(A) RNA (blue, f) and tRNA (green, 217 g) and upon addition of the Tau aggregation inducer, heparin (black, h). Remarkably, the EPR 218 lineshape of Δtau187/322C-SL within the droplet phase was indistinguishable from the dilute 219 solution state ( Fig. 4f vs. 4g). In contrast, the EPR line shape dramatically broadened within 220 minutes of adding heparin-a highly effective aggregation inducer of Tau [1, 25] ( Fig. 4f vs. 
4h). 221
This finding demonstrates that the condensation of Δtau187 to high protein concentration alone 222 does not effectively induce dehydration and aggregation of Tau, and that Tau remains dynamic 223 and hydrated and retains protein dynamical properties as found in solution state, despite forming 224 long-range associations with RNA in a highly condensed fluid phase. 225
To determine whether Tau assumes altered protein conformations in the complex 226 coacervate phase compared to the dilute solution phase, we compared the PHF6 and PHF6 * 227 hexapeptide regions of Tau under these conditions. These regions of the Tau sequence pack into 228 the β-sheet core once fibrils are formed of Tau [26] . Previously, we identified that both the PHF6 229 and PHF6 * hexapeptide regions of Tau undergo a dramatic opening from a compact to a fully 230 extended local conformation within minutes of adding heparin, well before fibril formation is 231 seen and remain extended as insoluble fibrils are formed (unpublished data). These local distance 232 measurements of the regions flanking the PHF6 ( * ) regions offer a powerful tool to compare the 233 conformational state of Tau in dilute solution, droplet and aggregation-induced states. We 234 prepared a Δtau187 G272C/S285C-SL 2 construct that was doubly MTSL-labeled at sites 272 and 235 285 (see Methods) to access the distances across the PHF6 * hexapeptide region by double 236 electron-electron resonance (DEER) spectroscopy. Surprisingly, the distances flanking the 237 PHF6* region remained unchanged from dilute solution state to when Tau was condensed into a 238 concentrated complex coacervate phase in association with poly(A) RNA and tRNA ( Fig. 4i and 239 j). This contrasts with the effect of heparin on Tau that markedly extended the segment distances 240 (from ~3 to ~4 nm) between the labels, within minutes of heparin addition, corresponding to the 241 extended conformation that the PHF6 (*) segment adopts in insoluble fibrils when neatly stacked 242 in β-sheets ( Fig. 4k ). 243
Interestingly, we observed a low-level Thioflavin T (ThT) signal under Tau-poly(U) 244 RNA droplet forming conditions (see Fig. S5f ) that gradually increased with time over 12 hours. 245
This ThT signal was nearly entirely diminished at increased salt concentration at which Tau-246 RNA associations are weakened and droplets are resolved. Still, the ThT intensity from the Tau-247 RNA droplet samples, even after three days of incubation, was significantly smaller (less than 248 5%) compared to what was observed in the presence of the aggregation-inducing heparin under 249 similar charge ratio and mass concentration at any incubation time ( Fig. S5f ). Since ThT 250 intensity is commonly used as an assay to map β-sheet content, we suggest that droplet formation 251 through association with RNA increases the aggregation propensity of Tau in vitro, even while 252 the Tau-RNA complexes are held together by fully reversible weak interactions. 253 254
Exogenous tRNA can induce sarkosyl insolubility of Tau 255
To determine whether Tau-RNA complexes have the potential for pathological 256 interactions in vivo, hiPSC-derived neurons with a P301L mutation or wild type were transfected 257 with 20U tRNA per 1.2 million cells. Cell lysates (input) were prepared in a high salt/high 258 sucrose buffer, followed by fractionation in a 1% sarkosyl buffer. Transfection in the absence of 259 nucleic acids (mock) or addition of tRNA to the mock lysate (mock + tRNA) were used as 260 controls. Cells transfected with tRNA accumulated sarkosyl insoluble Tau, whereas cells without 261 added tRNA or when tRNA was added to the lysis buffer did not increase Tau in the insoluble 262 fractions (Fig. 5 ). The increase in sarkosyl-insoluble Tau populations occurred in both wild-type 263 and P301L Tau-containing cells when infected with tRNA. 264 265 Discussion 266 Tau can bind RNA in two stages, mediated by (i) strong binding at a Tau:RNA molar 267 ratio of 2:1 with nanomolar dissociation constants and (ii) weak association between Tau 268 multimers and RNA to form higher order complexes. Although Tau lacks a recognizable RNA-269 binding motif, it bound tRNA as its dominant partner in vivo. Furthermore, Tau was found to 270 spontaneously phase separate upon non-specific complexation with RNA into dense protein 271 droplets, whose formation was reversibly and sensitively tunable by salt concentrations, as well 272 as the Tau:RNA ratios. Crucially, the optimal Tau:RNA molar ratios range from 8:1 to 330:1, 273 which varies among different RNA species. Remarkably, all higher order complexes converge to 274 a common Tau:RNA charge ratio of ~1:1, leading us to conclude that Tau-RNA droplet 275 formation is driven by electrostatic interactions underlying complex coacervation, in which 276 oppositely charged polyelectrolytes associate into extended assemblies held together by weak 277 electrostatic interactions and condense to a macroscopic fluid phase [14, 17, 27] . between the dilute and condensed phase [14] . The Tau droplet state fits this biochemical portrait, 301 so that Tau can reversibly and rapidly switch between the dilute solution and the dense droplet 302 state, while involving minimal rearrangement of hydration water and protein conformations. The 303 spontaneous complex coacervation from synthetic polyelectrolyte constituents can be entropy-304 driven according to several studies [6, 23, [28] [29] [30] . We found that Tau-RNA complex 305 coacervation was enhanced at elevated temperatures, consistent with an entropy-driven reaction 306 (data not shown). In fact, the observation of solution state-like protein conformational dynamics 307 of Tau in the coacervate phase implies that the free energy penalty due to lowering of protein 308 configurational entropy from protein ordering is minimal in the droplet state, and thus the cost 309 for an entropy-driven complex coacervation reaction, paid by salt and/or water release, is small. 310
Given this insight, we conclude that the transformation to insoluble aggregates from Tau droplets 311 should be energetically more favorable than from dilute solution state, given the elevated protein 312 concentration in the complex coacervate phase. Along these lines ten Wolde and Frenkel [31] 313 have proposed that condensed liquid droplets serve as a "metastable crucible" to lower free 314 energy barriers for crystal nucleation, while the discovery of the involvement of nucleic acids in RNA-protein complexes from CLIP experiments (Fig. 1a-c) were cut from the blot, and the RNA 374 extracted followed by reverse transcription for library preparation [36] . The 32 P-labeled RNA 375 band was run on a polyacrylamide Tris-Borate Urea (TBU) denaturing gel to demonstrate the 376 confirm the size of the complex. 377 378
Library preparation, deep sequencing and bioinformatics analysis of iCLIP 379
The iCLIP libraries contained an experimental and a random barcode, which allowed 380 multiplexing and the removal of PCR duplicates. After the barcodes were introduced, sample and 381 control from one set of experiments were mixed to remove batch-to-batch variation. Libraries 382 were sequenced on an Ion Torrent Proton. Fastx collapser from FASTX-Toolkit was used to 383 collapse reads and filter replicates resulting from the PCR based on the random barcode. Reads 384 were separated into samples by the barcodes at the 5` ends of reads. The reverse transcription 385 primers sequences at both ends of the reads were trimmed with Cutadapt [40] . After trimming 386 the barcodes, reads with 18 bps or more were kept and counted as total unique reads, and aligned 387 to the human genome (hg19) by Bowtie2 [41] . RseQC [42] was used to evaluate the quality of 388 sequencing and mapping reads. Alignments with scores equal or greater than ten were kept for 389 downstream analysis. Reads from these RNA pools were clustered by their alignments, and 390
Pyicos tools [43] were used to identify the significant clusters. Clusters with at least five reads 391 were retained and considered to contain target sites for RNA-Tau crosslinking. Gene models for 392
RefSeq mRNAs, tRNAs, rRNAs were downloaded from the UCSC genome browser. miRNAs UV spectrophotometry after base-hydrolization to account for the hyperchromic effect from the 422 secondary and tertiary structure of tRNA [20] . RNA43 was purchased in a kit (Pierce) with the 423 sequence 5'-CCUGGUUUUUAAGGAGUGUCGCCAGAGUGCCGCGAAUGAAAAA-3' to 424 represent a random sequence. The hydrolyzed tRNA and RNA43 samples were then quantified 425 with UV spectrophotometry at 260 nm using an extinction coefficient of 0.025 (µg/ml) -1 cm -1 . For 426 the gel shift assay, protein was incubated with tRNA at 37 C for 10 minutes in the presence of 427 0.5 mM EDTA, 0.5 mM MgCl 2, 2 U SUPERase• In™ RNase Inhibitor (Thermo Fisher), 0.01% 428 IGEPAL CA-630 (Sigma-Aldrich), and then applied to a TBE 8% Polyacrylamide Gel (Thermo 429 Fisher). After gel separation, tRNA was stained with SYBR Gold II (Thermo Fisher). For 430 quantitative analysis, the fraction of free and bound tRNA was quantified in ImageJ2 (National 431 Institute of Health). 432
Isothermal Titration Calorimetry (ITC) experiments 434
Full length Tau or the K18 Tau were dialyzed overnight into a specified buffer for ITC (20 mM 435 ammonium acetate, pH 7). tRNA (from Baker's yeast, Sigma-Aldrich) was re-suspended in the 436 ITC buffer and concentration determined using a Nanodrop 1000 (Thermo Scientific). 437
Experiments were run on a Nano ITC (TA Instruments), in which 300 µM tRNA was titrated (5 438 µl injections) into a 1 ml protein solution of 30 µM Tau. Data was analyzed using the 439 NanoAnalyze v3.6 software (TA Instruments). After substracting the heat generated by tRNA 440 titration into empty buffer, the experimental data was fitted with an Independent binding model. 441
Experiments were repeated in triplicates and standard error of the mean reported. 442 443
Spin labeling of Δtau187 444
To achieve labeling with paramagnetic or diamagnetic probes, the protein was dissolved in 6 M 445 guanidinium hydrochloride and labeled overnight at 4°C using a 20-fold molar excess of the spin 446 label (1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl) methanethiosulfonate (MTSL, Toronto 447 Research Chemicals) or the diamagnetic analog of MTSL (1-Acetoxy-2,2,5,5-tetramethyl-δ-3-448 pyrroline-3-methyl) methanethiosulfonate (Toronto Research Chemicals). Excess label was 449 removed using a PD-10 desalting column (GE Healthcare) equilibrated in a 20 mM ammonium 450 acetate buffer at pH 7.0. The protein was concentrated using a 3 kDa centrifugal filter (Amicon 451 UFC800396). The final protein concentration was determined by UV-Vis absorption at 274 nm 452 using an extinction coefficient of 2.8 cm -1 mM -1 , calculated from extinction coefficient of 453
Tyrosine [46] . The two variants Δtau187/322C and Δtau187G272C/S285C were spin labeled 454 with paramagnetic MTSL probes at the one or two cysteine sites, and are respectively referred to 455 as Δtau187/322C-SL and Δtau187G272C/S285C-SL 2 . In order to achieve spin dilution, 456
Δtau187/322C and Δtau187G272C/S285C were also labeled with the diamagnetic analogue of 457 MTSL probes, and are referred to as Δtau187/322C/322C-DL and Δtau187G272C/S285C-DL 2 . 458 Images in Fig. 4a-b were taken using 400 µM Tau, 800 µg/ml poly(A) RNA and 30% glycerol in 459 20 mM ammonium acetate at pH 7. 460 461
Preparation of Tau-RNA complex coacervate 462
Droplets were formed in the 20 mM ammonium acetate buffer with NaCl concentration varying 463 between 0 and 100 mM and glycerol concentration from 0 to 50% v/v. Solutions of Δtau187 or 464 full length 4R2N Tau was mixed with tRNA (Baker's yeast, Sigma-Aldrich), poly(A) RNA or 465 poly(U) RNA (Sigma-Aldrich) at varying protein, RNA, NaCl and glycerol concentrations in a 466 0.6 ml Eppendorf tube. RNAs were weighted out as powder and the mass concentration was 467 calculated. The Tau:RNA mass ratio, the total concentration of Tau and RNA, as well as the 468 NaCl salt concentration were optimized to maximize droplet formation, while choosing a total 469 biopolymer density to avoid overlapping of droplets in the images to simplify the calculation of 470 droplet coverage. Microscopy images were acquired at 10 minutes after mixing. A concentration 471 of 19% v/v for the viscogen glycerol was determined to be an optimal concentration to ensure 472 cryoprotection for DEER measurements carried out at ~80 K, while also ensuring maximal 473 droplet formation at room temperature (Fig. S5b) . 474
The charge of a peptide at a given pH was estimated by applying an algorithm adapted from 475
Innovagen's Peptide Property Calculator (http://pepcalc.com/). All residues were assumed to 476
have pKa values that are equivalent to the isolated residues (CRC Handbook of Chemistry and 477
Physics, 87th ed). Charges of the C-terminus or N-terminus were estimated as -1 and +1, 478 respectively at both pH 6.0 and pH 7.0. The processing code is made available as supplementary 479 files on the free web (https://github.com/yanxianUCSB/PeptideChargeCalculator). 480 481 Bright-field microscopy of Tau-RNA droplets 482
Immediately after mixing Tau in a 0.6 ml Eppendorf tube with RNA under droplet forming 483 conditions (established above) and ensuring thorough mixing, 1 µl of this mixture was applied to 484 a microscope slide that is closed with a cover slide gapped by two layers of double-side sticky 485 tape to generate a liquid sample region with consistent thickness. The microscope slide was kept 486 at room temperature for 10 minutes with the cover slide facing down, during which the particles 487 within the liquid sample region settled down onto the surface of the cover slide. Images were 488 taken with a 12-bit CCD camera across the entire sample liquid region near the surface of the 489 cover slide using an inverted compound microscope (Olympus IX70). Before imaging, Köhler 490 illumination was applied and the focus close to the surface of the cover slide optimized to 491 enhance the contrast between the dark droplets and the bright background. 492 493
Confocal microscopy of Tau-RNA droplets 494
For confocal microscopy, Δtau187/322C was fluorescently labeled (Δtau187/322C-FL) with 495
Alexa Fluor 488 C 5 Maleimide (Thermo Fisher) at the same 322 site as Δtau187/322C-SL. 50 496 µM of Δtau187/322C-FL was mixed with 350 µM Δtau187/322C-SL at a 1:7 molar ratio in order 497 to prevent saturation. 800 µg/ml of poly(A) RNA was further added to this Tau solution, 498 resulting in droplet formation in the 20 mM ammonium acetate buffer and in the presence of 20 499 mM NaCl. 10 µL of the mixture was pipetted and put on a microscope slide with a cover slide 500 gapped by double-sided sticky tape. Confocal images were acquired using a spectral confocal 501 microscope (Olympus Fluoview 1000). 502 503
Droplet quantification from image analysis 504
To quantify the amount of droplet formed under the given experimental condition of interest, 505 images were taken by a 12-bit CCD camera of an inverted compound microscope (Olympus 506 IX70), and recorded in TIF format. With illumination and focus optimized, droplets settling on 507 the cover slide have lower intensity than their surrounding on the images. An image of the 20 508 mM ammonium acetate buffer was taken to calculate the average intensity to set as threshold in 509 order to classify different parts of the image into droplets and buffer. For each image, the area of 510 the droplets was divided by the total area of the image, generating a % droplet coverage value on 511 the cover slide. Droplets with eccentricity above 0.9 or equivalent diameter below 1 µm were 512 filtered out in order to reduce false reading. The MATLAB code is made available as 513 supplementary files on the free web (https://github.com/yanxianUCSB/DropletAnalysis). 514 515
Continuous wave (cw) Electron Paramagnetic Resonance (EPR) 516
Cw EPR relies on the anisotropy of nitroxide radical's Larmor frequency and hyperfine coupling 517 that makes its lineshape highly sensitive to the local dynamics, orientation and confinement of a 518 nitroxide-based spin label tethered to the protein. Cw EPR measurements were carried out with 519 Δtau187/322C-SL using a X-band spectrometer operating at 9.8 GHz (EMX, Bruker Biospin) 520 and a dielectric cavity (ER 4123D, Bruker Biospin). Samples were prepared by either mixing 521 200 µM Δtau187/322C-SL with 300 µM unlabeled Δtau187/322C (to generate 40% spin labeled 522 sample) or by using 500 µM Δtau187/322C-SL (100% labeled). Viscogen was added to the 523 sample to achieve either 19% v/v glycerol (for the droplet samples) or 30% v/v sucrose (for the 524 aggregated samples) matching the DEER conditions. Tau samples under droplet forming 525 condition were prepared by adding 1.5 mg/ml RNA, and Tau samples under aggregation-526 inducing conditions prepared by adding 125 µM heparin (11 kDa average MW, Sigma-Aldrich). 527 A sample of 3.5 µL volume was loaded into a quartz capillary (VitroCom, CV6084) and sealed 528 at one end with critoseal and the other with beeswax, and then placed in the dielectric cavity for 529 measurements. Cw EPR spectra were acquired using 2 mW of microwave power, 0.3 gauss 530 modulation amplitude, 150 gauss sweep width and 25 scans for signal averaging. 531 532
Double Electron Electron Resonance (DEER) 533
DEER measurements were performed on a Q-band pulsed EPR spectrometer operating at 32 534 GHz (E580, Bruker Biospin) equipped with a QT2 resonator (measurements done by courtesy of 535 Bruker Biospin). Samples were prepared by mixing 50 µM Δtau187G272C/S285C-SL 2 with 500 536 µM analog-labeled Δtau187G272C/S285C-DL 2 at a 1:10 molar ratio to achieve spin-dilution and 537 avoid artifacts from unwanted inter-protein spin distances. For DEER, Tau samples under droplet 538 forming condition were prepared by adding 1.65 mg/ml RNA and ensuring 19% v/v glycerol 539 concentration, and Tau samples under aggregation-inducing conditions prepared by adding 137.5 540 µM heparin and ensuring 30% v/v sucrose concentration. 40 µL samples containing 550 µM 541 concentration of Tau were loaded into a quartz capillary (2.4 mm od x 2 mm id) and flash frozen 542 in liquid nitrogen after 20 minutes of incubation at room temperature. DEER measurements were 543 conducted using the dead-time free four-pulse DEER sequence at 80 K, using 22 ns (π/2) and 44 544 ns (π) observe pulses and a 30 ns (π) pump pulse. The raw DEER data was processed using 545 with a cell scraper, followed by mechanical dissociation using a micropipette. Immediately 565 afterwards, the lysates were centrifuged at 4°C 3000 x g for 15 min in a microcentrifuge. The 566 clear supernatants were collected and sampled (Input). Sodium lauroyl sarcosinate ( Sigma-567 Aldrich) was then added to the supernatants to a final concentration of 1%, followed by a brief 568 vortexing. Samples were incubated at 4°C with continuous rocking. Samples were then 569 centrifuged at 4°C for 2 h at 170000 x g in a Beckman Coulter 70.1 Ti rotor. Sarkosyl soluble 570 supernatants (Sol.) were collected. Sarkosyl insoluble (Ins.) pellets were resuspended in 2X 571 sample loading buffer (250 mM Tris HCl pH 6.8, 10% Glycerol, 10% SDS, 0.5% bromophenol 572 blue, 20 mM DTT) and heated to 95°C for 10 min. The previously collected input and the 573 sarkosyl soluble fractions were diluted with the same sample loading buffer, and heated under 574 similar conditions. Proteins were separated on a 10% SDS-PAGE, transferred to Nitrocellulose 575 membranes, and blotted with either PHF-1 or β-actin antibody. 576 577
Data availability 578
The data that support the findings of this study are available from the corresponding authors on 579 request. 580 581 Acknowledgments 582
We are grateful to the Tau consortium for financial support to K.S.K. and S.H., D. M. Holtzman, 583
Washington University School of Medicine for the generous gift of HJ 8.5 antibody and P. 
